We are live on
!
Find out more
AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
113 hedge funds and large institutions have $551M invested in Accelerate Diagnostics in 2019 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 33 increasing their positions, 26 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
27% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 26
7% less call options, than puts
Call options by funds: $9.5M | Put options by funds: $10.2M
3% less funds holding
Funds holding: 117 → 113 (-4)
16% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 19
19% less capital invested
Capital invested by funds: $679M → $551M (-$127M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
113
Holders Change
-4
Holders Change %
-3.42%
% of All Funds
2.48%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.09%
New
16
Increased
33
Reduced
26
Closed
19
Calls
$9.5M
Puts
$10.2M
Net Calls
-$692K
Net Calls Change
-$1.43M
Top Buyers
| 1 |
CC
Chicago Capital
Chicago,
Illinois
|
+$6.48M |
| 2 |
GAM
Griffin Asset Management
New York
|
+$5.12M |
| 3 |
Morgan Stanley
New York
|
+$2.01M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.49M |
| 5 |
TWA
TCI Wealth Advisors
Tucson,
Arizona
|
+$1.07M |
